Lv11
46 积分 2025-03-04 加入
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
1小时前
待确认
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
1个月前
已完结
Durable response to an anti-CD25 antibody-drug conjugate and anti-PD-1 antibody in ovarian carcinoma: a case report
1个月前
已完结
Antibody-bottlebrush prodrug conjugates for targeted cancer therapy
2个月前
已完结
Antibody-bottlebrush prodrug conjugates for targeted cancer therapy
2个月前
已完结
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg‐Depleting Antibody
5个月前
已完结
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg‐Depleting Antibody
5个月前
已完结
PF-08046032: A novel, investigational CD25-directed antibody-drug conjugate optimized for selective depletion of regulatory T cells in advanced malignant tumors
6个月前
已完结
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma
8个月前
已完结
Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1
8个月前
已完结
皖公网安备34019202002308
